Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

Monday’s trading has closed, but AGN is being traded in the after-hours session. After-Hours quote »
266.30
Delayed Data
As of 4:02pm ET
 -7.50 / -2.74%
Today’s Change
237.50
Today|||52-Week Range
340.34
-14.78%
Year-to-Date

Today’s Trading

Previous close273.80
Today’s open270.60
Day’s range261.60 - 272.66
Volume3,268,478
Average volume (3 months)4,223,732
Market cap$107.9B
Dividend yield--
Data as of 4:02pm ET, 02/08/2016

Growth & Valuation

Earnings growth (last year)-40.80%
Earnings growth (this year)+10.32%
Earnings growth (next 5 years)+10.02%
Revenue growth (last year)+50.53%
P/E ratioNM
Price/Sales4.33
Price/Book2.57

Competitors

 Today’s
change
Today’s
% change
SNYSanofi-0.61-1.53%
BMYBristol-Myers Squibb+1.09+1.83%
GSKGlaxoSmithKline-1.29-3.16%
NVONovo Nordisk-1.88-3.84%
Data as of 4:02pm ET, 02/08/2016

Financials

Next reporting dateFebruary 22, 2016
EPS forecast (this quarter)$3.34
Annual revenue (last year)$13.1B
Annual profit (last year)-$1.6B
Net profit margin-12.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Brenton L. Saunders
President-Generic &
Global Operations, EVP
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers